Literature DB >> 26320420

The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia.

Dale Carcione1, Annette K Regan2, Lauren Tracey3, Donna B Mak4, Robyn Gibbs3, Gary K Dowse3, Max Bulsara5, Paul V Effler2.   

Abstract

During a pertussis epidemic in 2011-2012 the Western Australian (WA) Department of Health implemented a 'cocooning' programme, offering free pertussis-containing vaccine (dTpa) to new parents. We assessed the impact of vaccinating parents with dTpa on the incidence of pertussis infection in newborns. Births in WA during 2011-2012 were linked to a register of parental pertussis vaccinations and to notified reports of laboratory-proven pertussis in children <6 months of age. Parents who received dTpa during the four weeks after their child's birth were defined as 'vaccinated postpartum.' Cox proportional-hazards methods were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of pertussis infection among infants born to parents vaccinated postpartum vs. unvaccinated parents, adjusted for maternal age, geographic region, timing of birth, and number of siblings. Of 64,364 live-births, 43,480 (68%) infants had at least one vaccinated parent (60% of mothers and 36% of fathers). After excluding records where parent(s) were either vaccinated prior to the birth, vaccinated >28 days after the birth, the vaccination date was uncertain, or the child died at birth (n=42), the final cohort contained 53,149 children, 118 of whom developed pertussis. There was no difference in the incidence of pertussis among infants whose parents were both vaccinated postpartum compared to those with unvaccinated parents (1.9 vs 2.2 infections per 1000 infants; adjusted HR 0.91; 95%CI 0.55-1.53). Similarly, when assessed independently, maternal postpartum vaccination was not protective (adjusted HR 1.19; 95%CI 0.82-1.72). Supplemental sensitivity analyses which varied the time period for parental vaccination and accounted for under-reporting of vaccination status did not significantly alter these findings. In our setting, vaccinating parents with dTpa during the four weeks following delivery did not reduce pertussis diagnoses in infants. WA now provides dTpa vaccine to pregnant women during the third trimester.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bordetella pertussis; Cocooning; Immunisation; Pertussis vaccine; Public health; Whooping cough

Mesh:

Substances:

Year:  2015        PMID: 26320420     DOI: 10.1016/j.vaccine.2015.08.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women.

Authors:  Eleonora Agricola; Francesco Gesualdo; Lia Alimenti; Elisabetta Pandolfi; Emanuela Carloni; Angelo D'Ambrosio; Luisa Russo; Ilaria Campagna; Beatrice Ferretti; Alberto E Tozzi
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

2.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

3.  An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.

Authors:  Amy E Blain; Melissa Lewis; Emily Banerjee; Kathy Kudish; Juventila Liko; Suzanne McGuire; David Selvage; James Watt; Stacey W Martin; Tami H Skoff
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

4.  Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection.

Authors:  Saskia van der Lee; Susanne P Stoof; Mariette B van Ravenhorst; Pieter G M van Gageldonk; Nicoline A T van der Maas; Elisabeth A M Sanders; Anne-Marie Buisman; Guy A M Berbers
Journal:  Euro Surveill       Date:  2017-11

Review 5.  The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis.

Authors:  Christopher Gill; Pejman Rohani; Donald M Thea
Journal:  F1000Res       Date:  2017-08-25

6.  Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.

Authors:  Péter Torzsa; Raghavendra Devadiga; Monica Tafalla
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

7.  Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.

Authors:  Tami H Skoff; Amy E Blain; James Watt; Karen Scherzinger; Melissa McMahon; Shelley M Zansky; Kathy Kudish; Paul R Cieslak; Melissa Lewis; Nong Shang; Stacey W Martin
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

8.  Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

Authors:  Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.